DuraGraft is a vascular graft treatment that improves clinical outcomes by reducing the incidence and complications of graft failure.

DuraGraft enhances CABG outcomes by significantly reducing major cardiac events such as repeat revascularization, myocardial infarction and MACE. Learn more about DuraGraft.

Based on US Retrospective Study - more than 2000 CABG Patients

48%

Reduction in
Myocardial Infarction
p=0.0001

53%

Reduction in
Repeat Revascularization
p=0.02

*Manuscript in preparation

18%

Reduction in
MACE
p=0.02